Skip to main content
Scleromyxedema secondary to hepatitis c virus and successfully treated with antiviral therapy
Published Web Locationhttps://doi.org/10.5070/D3219028690
Scleromyxedema (SM) is a chronic and progressive fibromucinous disease with no known etiology. We report a patient with scleromyxedema associated with hepatitis C virus, successfully treated with interferon and ribavirin therapy.
For improved accessibility of PDF content, download the file to your device.